Flora Growth (FLGC) Competitors $0.68 -0.02 (-2.34%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$0.68 0.00 (0.00%) As of 07/11/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. AVTX, ABVC, CUE, GANX, ATRA, RNXT, RENB, ZIVO, QNTM, and CRVOShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Avalo Therapeutics (AVTX), ABVC BioPharma (ABVC), Cue Biopharma (CUE), Gain Therapeutics (GANX), Atara Biotherapeutics (ATRA), RenovoRx (RNXT), Renovaro (RENB), ZIVO Bioscience (ZIVO), Quantum Biopharma (QNTM), and CervoMed (CRVO). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors Avalo Therapeutics ABVC BioPharma Cue Biopharma Gain Therapeutics Atara Biotherapeutics RenovoRx Renovaro ZIVO Bioscience Quantum Biopharma CervoMed Avalo Therapeutics (NASDAQ:AVTX) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends. Which has more risk & volatility, AVTX or FLGC? Avalo Therapeutics has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Do institutionals and insiders hold more shares of AVTX or FLGC? 87.1% of Avalo Therapeutics shares are owned by institutional investors. Comparatively, 36.0% of Flora Growth shares are owned by institutional investors. 3.0% of Avalo Therapeutics shares are owned by company insiders. Comparatively, 12.6% of Flora Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better earnings & valuation, AVTX or FLGC? Flora Growth has higher revenue and earnings than Avalo Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvalo Therapeutics$440K117.65-$35.13MN/AN/AFlora Growth$59.51M0.26-$15.91M-$0.98-0.70 Is AVTX or FLGC more profitable? Avalo Therapeutics has a net margin of 0.00% compared to Flora Growth's net margin of -24.85%. Avalo Therapeutics' return on equity of 111.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Avalo TherapeuticsN/A 111.00% 58.88% Flora Growth -24.85%-216.49%-45.56% Do analysts rate AVTX or FLGC? Avalo Therapeutics currently has a consensus target price of $30.00, suggesting a potential upside of 527.62%. Flora Growth has a consensus target price of $4.00, suggesting a potential upside of 483.94%. Given Avalo Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Avalo Therapeutics is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avalo Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Flora Growth 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media prefer AVTX or FLGC? In the previous week, Avalo Therapeutics had 1 more articles in the media than Flora Growth. MarketBeat recorded 2 mentions for Avalo Therapeutics and 1 mentions for Flora Growth. Flora Growth's average media sentiment score of 1.90 beat Avalo Therapeutics' score of 0.63 indicating that Flora Growth is being referred to more favorably in the news media. Company Overall Sentiment Avalo Therapeutics Positive Flora Growth Very Positive SummaryAvalo Therapeutics beats Flora Growth on 9 of the 14 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.46M$10.47B$5.56B$9.10BDividend YieldN/A2.09%5.06%4.02%P/E Ratio-0.7017.1228.2620.26Price / Sales0.2630.05427.70153.06Price / CashN/A22.5637.1257.67Price / Book2.213.668.045.49Net Income-$15.91M$235.43M$3.19B$250.45M7 Day Performance7.87%1.27%3.62%4.79%1 Month Performance-7.73%5.34%5.98%9.59%1 Year Performance-36.57%-15.78%29.39%16.41% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth2.4839 of 5 stars$0.69-2.3%$4.00+483.9%-36.6%$15.46M$59.51M-0.70280Positive NewsAVTXAvalo Therapeutics2.96 of 5 stars$4.75-4.2%$30.00+531.6%-60.7%$53.71M$440K0.0040News CoverageABVCABVC BioPharma0.4023 of 5 stars$3.99+28.3%N/A+401.9%$52.81M$510K-30.6930News CoverageGap UpHigh Trading VolumeCUECue Biopharma4.074 of 5 stars$0.70+0.7%$3.00+328.4%-18.5%$52.38M$9.29M-1.0560Gap DownGANXGain Therapeutics2.2002 of 5 stars$1.60-5.3%$8.20+412.5%+25.4%$50.61M$50K-1.8620News CoveragePositive NewsATRAAtara Biotherapeutics4.552 of 5 stars$8.58+1.3%$17.75+106.9%-11.8%$50.46M$128.94M-2.31330Gap DownRNXTRenovoRx2.4182 of 5 stars$1.32-2.9%$7.25+449.2%-0.5%$49.74M$240K-3.306Positive NewsGap DownRENBRenovaro1.935 of 5 stars$0.30+2.6%N/A-81.4%$49.72MN/A-0.3920News CoverageZIVOZIVO BioscienceN/A$13.00+8.4%N/A+59.8%$49.62M$15.85K-2.6610QNTMQuantum BiopharmaN/A$16.56-2.9%N/AN/A$49.60MN/A-1.04N/ACRVOCervoMed3.3421 of 5 stars$5.87+3.9%$27.63+370.6%-55.2%$49.17M$9.74M-2.694Positive NewsGap Up Related Companies and Tools Related Companies AVTX Competitors ABVC Competitors CUE Competitors GANX Competitors ATRA Competitors RNXT Competitors RENB Competitors ZIVO Competitors QNTM Competitors CRVO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
